Nemours Children's Hospital is a freestanding, 130-bed, pediatric acute care children's hospital in Orlando, Florida. It is affiliated with the University of Central Florida College of Medicine and is a member of the Nemours Children's Health System, one of two hospitals in the system.

There are 130 beds in Nemours Childrens Hospital.

During the past decade, Nemours Childrens Hospital conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 120 clinical trials were completed, i.e. on average, 97.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 49 clinical trials were completed. i.e. 148.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemours Childrens Hospital" #1 sponsor was "Children's Oncology Group" with 131 trials, followed by "National Cancer Institute (NCI)" with 61 trials sponsored, "Nemours Children's Clinic" with 10 trials sponsored, "Gilead Sciences" with 6 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 6 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemours Childrens Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 134 trials as a collaborator, "Children's Oncology Group" with 10 trials as a collaborator, "Cystic Fibrosis Foundation" with 8 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator. Other collaborators include 116 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Nemours Childrens Hospital" are "Cystic Fibrosis" (24 trials), "Recurrent Neuroblastoma" (21 trials), "Recurrent Osteosarcoma" (19 trials), "Refractory Neuroblastoma" (15 trials) and "Leukemia" (14 trials). Many other conditions were trialed in "Nemours Childrens Hospital" in a lesser frequency.

Most popular intervention types in "Nemours Childrens Hospital" are "Drug" (227 trials), "Other" (120 trials), "Procedure" (80 trials), "Biological" (75 trials) and "Radiation" (55 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Cyclophosphamide" (40 trials), "Vincristine Sulfate" (35 trials), "Questionnaire Administration" (32 trials) and "Etoposide" (28 trials). Other intervention names were less common.

The vast majority of trials in "Nemours Childrens Hospital" are 283 trials for "All" genders, 17 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Nemours Childrens Hospital". 2 are not yet recruiting, 56 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 148 completed trials in Nemours Childrens Hospital, 2 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Nemours Childrens Hospital, 16 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 118 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 18 trials that are defined as “Not Applicable".